Celldex Therapeutics, Inc. Intangible Assets, Gross (Excluding Goodwill)
Celldex Therapeutics, Inc. (CLDX) had Intangible Assets, Gross (Excluding Goodwill) of $74.99 million as of 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Notes › Goodwill and Other
us-gaap:IntangibleAssetsGrossExcludingGoodwill · last filed 2018-11-07
- 2018-09-30: Intangible Assets, Gross (Excluding Goodwill) $74.99M.
- 2018-06-30: Intangible Assets, Gross (Excluding Goodwill) $74.99M.
- 2018-03-31: Intangible Assets, Gross (Excluding Goodwill) $74.99M.
- 2017-12-31: Intangible Assets, Gross (Excluding Goodwill) $74.99M.
| Period end | Intangible Assets, Gross (Excluding Goodwill) | Intangible Assets, Gross (Excluding Goodwill) as first filed |
|---|---|---|
| 2018-09-30 | $74.99M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $74.99M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $74.99M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $74.99M 10-Q · filed 2018-11-07 | |
| 2017-09-30 | $74.99M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $87.99M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $87.99M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $87.99M 10-K · filed 2018-03-07 | $89.29M 10-K · filed 2017-03-14 |
| 2016-09-30 | $27.60M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $27.60M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $27.60M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $27.60M 10-K · filed 2017-03-14 | |
| 2015-09-30 | $27.60M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $27.60M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $27.60M 10-Q · filed 2015-04-29 | |
| 2014-12-31 | $27.60M 10-K/A · filed 2016-02-25 | |
| 2014-09-30 | $27.60M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $27.60M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $27.60M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $27.60M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $27.60M 10-Q · filed 2013-11-08 | |
| 2012-12-31 | $27.60M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |